Incidence of Arthritis in a Large Cohort of Pediatric Patients Diagnosed with Psoriasis
Clinical Scorecard: Incidence of Arthritis in a Large Cohort of Pediatric Patients Diagnosed with Psoriasis
At a Glance
| Category | Detail |
|---|
| Condition | Psoriatic Arthritis (PsA) in Pediatric Patients |
| Key Mechanisms | Development of JPsA associated with psoriasis severity, age at diagnosis, and uveitis. |
| Target Population | Pediatric patients with psoriasis (<18 years) and young adults (≥18 years) with a history of psoriasis. |
| Care Setting | Dermatology and Pediatric Rheumatology |
Key Highlights
- 2% of children with psoriasis developed JPsA over a mean follow-up of 5 years.
- Older age at psoriasis diagnosis and presence of uveitis are identified risk factors for JPsA.
- JPsA accounts for approximately 8% of the Juvenile Idiopathic Arthritis population.
- Diagnosis of JPsA is challenging, especially in patients without psoriatic lesions.
Guideline-Based Recommendations
Diagnosis
- Children diagnosed with JPsA according to ILAR criteria.
- Young adults diagnosed with PsA according to CASPAR criteria.
Management
- Referral to a rheumatologist based on persistent joint complaints and elevated PEST scores.
Monitoring & Follow-up
- Regular follow-up visits to assess PASI score, BSA, BMI, and nail involvement.
Risks
- Risk factors for developing JPsA include older age at psoriasis diagnosis and uveitis.
Patient & Prescribing Data
Pediatric patients with plaque psoriasis followed into young adulthood.
Data collected on treatment history and clinical characteristics at baseline and follow-up.
Clinical Best Practices
- Early diagnosis of psoriatic arthritis is crucial for prevention.
- Consider referral to rheumatology for patients with persistent joint symptoms.
Related Resources & Content
